The Impact of Hepatitis C Infection and Antiviral Therapy on clinical Outcome in Renal Transplantation Recipients
Hepatitis C viral infection (HCV) is presently a major problem in renal transplant recipients (RTR) with a high risk of chronicity resulting in liver cirrhosis. We screened 120 RTR (50 live related, 53 live unrelated, and 17 cadaveric); mean age of 45.2 years and mean post-transplant period of 6.8 y...
Main Authors: | Rashid Awad, Abboud Omar, Al-Kaabi Saad, Taha Mustafa, Ashour Adel, El-Sayed Mohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
1999-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=1999;volume=10;issue=1;spage=31;epage=35;aulast=Rashid |
Similar Items
-
Hypercholesterolemia in Renal Transplant Recipients; contributing Factors, Effect of Dietary Modification and Fluvastatin Therapy
by: Rahed Awad, et al.
Published: (1999-01-01) -
Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients
by: Sourabh Sharma, et al.
Published: (2018-01-01) -
POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01) -
Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience
by: Mohamad M. Alkadi, et al.
Published: (2021-03-01) -
Proteinuria in Egyptian renal transplant recipients
by: Essam Khedr, et al.
Published: (2015-01-01)